WallStreetZenWallStreetZen

NASDAQ: TNYA
Tenaya Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for TNYA

Based on 4 analysts offering 12 month price targets for Tenaya Therapeutics Inc.
Min Forecast
$7.00+49.25%
Avg Forecast
$15.75+235.82%
Max Forecast
$20.00+326.44%

Should I buy or sell TNYA stock?

Based on 4 analysts offering ratings for Tenaya Therapeutics Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TNYA stock forecasts and price targets.

TNYA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-21
lockedlocked$00.00+00.00%2024-03-20
lockedlocked$00.00+00.00%2024-03-19
lockedlocked$00.00+00.00%2023-11-30

1 of 1

Forecast return on equity

Is TNYA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.9%

Forecast return on assets

Is TNYA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

TNYA revenue forecast

What is TNYA's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$5.0M
Avg 2 year Forecast
$11.5M
Avg 3 year Forecast
$46.9M

TNYA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TNYA$4.69$15.75+235.82%Strong Buy
MGTX$5.73$11.00+91.97%Buy
FBLG$11.32N/AN/A
AVXL$4.45$40.00+798.88%Buy
EPIX$8.25$17.00+106.06%Buy

Tenaya Therapeutics Stock Forecast FAQ

Is Tenaya Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: TNYA) stock is to Strong Buy TNYA stock.

Out of 4 analysts, 2 (50%) are recommending TNYA as a Strong Buy, 2 (50%) are recommending TNYA as a Buy, 0 (0%) are recommending TNYA as a Hold, 0 (0%) are recommending TNYA as a Sell, and 0 (0%) are recommending TNYA as a Strong Sell.

If you're new to stock investing, here's how to buy Tenaya Therapeutics stock.

What is TNYA's revenue growth forecast for 2024-2026?

(NASDAQ: TNYA) Tenaya Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.55%.

Tenaya Therapeutics's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast TNYA's revenue for 2024 to be $392,580,710, with the lowest TNYA revenue forecast at $392,580,710, and the highest TNYA revenue forecast at $392,580,710. On average, 2 Wall Street analysts forecast TNYA's revenue for 2025 to be $902,935,633, with the lowest TNYA revenue forecast at $628,129,136, and the highest TNYA revenue forecast at $1,177,742,130.

In 2026, TNYA is forecast to generate $3,684,134,415 in revenue, with the lowest revenue forecast at $1,570,322,840 and the highest revenue forecast at $5,797,945,990.

What is TNYA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: TNYA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is TNYA's Price Target?

According to 4 Wall Street analysts that have issued a 1 year TNYA price target, the average TNYA price target is $15.75, with the highest TNYA stock price forecast at $20.00 and the lowest TNYA stock price forecast at $7.00.

On average, Wall Street analysts predict that Tenaya Therapeutics's share price could reach $15.75 by Mar 21, 2025. The average Tenaya Therapeutics stock price prediction forecasts a potential upside of 235.82% from the current TNYA share price of $4.69.

What is TNYA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: TNYA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.